Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Peringkat dalam Saham #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Harga Saham
$1.48
Terakhir disinkronkan: 2025-03-24
Kapitalisasi Pasar
$59.05M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Achilles Therapeutics plc (ACHL)

Kategori

Riwayat harga saham Achilles Therapeutics plc (ACHL)
Harga penutupan tertinggi: $1.42 pada 2025-03-01

Harga penutupan terendah: $16.55 pada 2021-03-01
Riwayat harga saham Achilles Therapeutics plc dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH